Identifying the major lactate transporter of Toxoplasma gondii tachyzoites

• Published in: Scientific reports 2021-03, Vol.11 (1), p.6787-6787, Article 6787
• Main Authors: Zeng, Joy M., Hapuarachchi, Sanduni V., Shafik, Sarah H., Martin, Rowena E., Kirk, Kiaran, van Dooren, Giel G., Lehane, Adele M.
• Format: Article
• Language: English
• Subjects: 631/326/417/1716; 631/45/612/1237; Genetic analysis; Genomes; Glycolysis; Humanities and Social Sciences; Lactic acid; multidisciplinary; Parasites; Protozoa; Science; Science (multidisciplinary); Tachyzoites; Therapeutic targets; Toxoplasma gondii
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-86204-3

Toxoplasma gondii and Plasmodium falciparum parasites both extrude l -lactate, a byproduct of glycolysis. The P. falciparum Formate Nitrite Transporter, Pf FNT, mediates l -lactate transport across the plasma membrane of P. falciparum parasites and has been validated as a drug target. The T. gondii genome encodes three FNTs that have been shown to transport l -lactate, and which are proposed to be the targets of several inhibitors of T. gondii proliferation. Here, we show that each of the Tg FNTs localize to the T. gondii plasma membrane and are capable of transporting l -lactate across it, with Tg FNT1 making the primary contribution to l -lactate transport during the disease-causing lytic cycle of the parasite. We use the Xenopus oocyte expression system to provide direct measurements of l -lactate transport via Tg FNT1. We undertake a genetic analysis of the importance of the tgfnt genes for parasite proliferation, and demonstrate that all three tgfnt genes can be disrupted individually and together without affecting the lytic cycle under in vitro culture conditions. Together, our experiments identify the major lactate transporter in the disease causing stage of T. gondii , and reveal that this transporter is not required for parasite proliferation, indicating that Tg FNTs are unlikely to be targets for anti- Toxoplasma drugs.